市場調査レポート
商品コード
1309864
核酸サンプル調製市場-世界の産業規模、動向、競合、機会、2018-2028年予測Nucleic Acid Sample Preparation Market- Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028 Segmented By Product, By Technology, By Therapeutic Area, By Application, By End Users,By Region and Competition |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
核酸サンプル調製市場-世界の産業規模、動向、競合、機会、2018-2028年予測 |
出版日: 2023年07月01日
発行: TechSci Research
ページ情報: 英文 116 Pages
納期: 2~3営業日
|
核酸サンプル調製市場は、2024-2028年の予測期間中に目覚ましいCAGRを記録すると予測されています。
この背景には、さまざまな治療領域で核酸分子の利用が拡大していることなどがあります。
ライフサイエンスにおける研究拡大のための政府、学術機関などによる投資の増加は、核酸サンプル調製市場の需要を促進すると予想されます。例えば、2022年2月、Brightlamp Inc.とPurdue-affiliated Amplified Sciences LLCは、Purdue Foundry Investment Fundから生命科学の進歩をもたらす研究開発のためにそれぞれ約25万米ドルの助成金を受け取っています。アンプリファイド・サイエンシズ社は、がんやその他の病気の事前診断のための先進技術の調査を行っています。同様に、ブライトランプ社は、機械学習とコンピューター・ビジョンを活用してヘルスケアを強化・改善する企業です。
迅速な疾病診断に対する需要の高まりと、複数の患者治療における診断情報の必要性により、明確な分子手順が開発され、その結果、診断手順に従うための核酸サンプル抽出が増加しており、核酸サンプル調製市場に有利な需要を提供すると予想されています。さらに、がんなどの慢性疾患の有病率の増加は、分子レベルでの診断の必要性を高めているため、核酸サンプル抽出と調製の需要の増加が予測期間中の市場成長を牽引しています。さらに、サンプル調製は、その安全性保証レベルやテーラーメイド治療の成功例から、精密医療において不可欠なアプリケーションです。
核酸単離/抽出は、分子診断やあらゆる分子実験室研究に関わる最も基本的なステップであり、サンプルの抽出に使用される機器や方法の多様化によって拡大しています。自動化された核酸抽出システムの利用可能性が、核酸サンプル調製市場の成長を後押ししています。さらに、自動化の進展は、最小のエラー率で同時に複数のサンプルを実行することにつながり、また、血清や組織、細胞培養のような異なるサンプルから核酸を抽出することができるため、核酸サンプル調製市場の加速が期待されています。例えば、2020年2月、市場の企業であるCovaris Inc.は、truXTRAC-PCR Direct viral RNA Extraction kitとtruXTRAC Viral RNA Extraction kitを含む、咽頭または鼻腔ぬぐい液採取装置によるウイルスRNA抽出のための2つの新しいキットを発表しました。
疾患における次世代シーケンシング(NGS)の需要の増加は、核酸サンプル調製市場の需要を促進しています。遺伝子または標的配列は、関心のある遺伝子または疾患保因者を担持しているため、同定して疾患診断に使用することができます。さらに、ターゲット配列決定によって、研究者は特定の関心遺伝子、コード領域、さらには染色体セグメントをターゲットにすることができ、正確、迅速、かつ精密なデータを収集するための配列決定に有用な技術となります。シーケンス手順用のキットや開発された試薬が入手可能であることが、予測期間中、市場の成長を支え、核酸サンプル調製市場を強化すると考えられています。
主要な市場参入企業は新製品を発表し、製品ポートフォリオを拡大しています。例えば、2020年2月、Miroculus Inc.は、ネストジェネレーションシーケンスライブラリー調製のような複雑なプロトコルを自動化、簡素化、小型化できる新システムMiro Canvasを発表しました。
所定の市場データを用いて、TechSci Researchは企業の特定のニーズに応じてカスタマイズを提供します。レポートでは以下のカスタマイズが可能です:
Nucleic Acid Sample Preparation Market is expected to register an impressive CAGR during the forecast period of 2024-2028. This can be attributed to factors such as the growing usage of nucleic acid molecules in various therapeutic areas.
Moreover, other factors, such as growing advancement in nucleic acid extraction and isolation techniques and growing demand for downstream applications such as Next Generation Sequencing (NGS), targeted sequencing, etc., drive the growth of the Nucleic Acid Sample Preparation market.
Increasing investment by the government, academics & institutions, etc., to expand research in life science is expected to drive the market demand for the Nucleic Acid Sample Preparation market. For instance, in February 2022, Brightlamp Inc. and Purdue-affiliated Amplified Sciences LLC received a grant of approximately US$ 250,000 each from the Purdue Foundry Investment Fund for R&D to bring advancement in life sciences. The Amplifies Sciences is researching advancing technology for pre-diagnosis of cancer and other diseases. Similarly, Brightlamp is a company that utilizes machine learning and computer vision to enhance and improve healthcare.
With the growing demand for disease diagnosis on time and the need for diagnostic information in several patient treatments, distinct molecular procedures are developed and thus are increasing the nucleic acid sample extraction to follow the diagnosis procedures and is anticipated to offer lucrative demand to the nucleic acid sample preparation market. Moreover, the growing prevalence of chronic diseases such as cancer is increasing the need for diagnosis at the molecular level, and thus increase in demand for nucleic acid sample extraction and preparation is driving the market growth during the forecast period. Moreover, sample preparation is an essential application in precision medicine on account of its safety assurance level and successful use of tailored therapies.
Nucleic acid isolation /extraction is the most basic step involved in molecular diagnosis or any molecular laboratory research and is expanding with the availability of a distinct range of equipment and methods used for the extraction of samples. The availability of automated nucleic acid extraction systems is bolstering the market growth for the nucleic acid sample preparation market. Moreover, increased automation has leads to running multiple samples at the same time with minimum error ratio and also can extract nucleic acid from distinct samples, such as serum and tissue, cell culture and thus is expected to accelerate the Nucleic Acid Sample Preparation Market. For instance, in February 2020, the market player Covaris Inc. introduced two new kits for viral RNA extraction with throat or nasal swab collection devices, which include the truXTRAC-PCR Direct viral RNA Extraction kit and truXTRAC Viral RNA Extraction kit.
The increased demand for Next-generation Sequencing (NGS) in disease is propelling the demand for the Nucleic Acid Sample Preparation market. The gene or targeted sequence carries a gene or interest or a disease carrier and thus can be identified and used in disease diagnosing. Additionally, targeted sequencing allows researchers to target particular genes of interest, coding areas, and even chromosomal segments, making it a useful technique for sequencing in order to collect accurate, quick, and precise data. The availability of kits and developed reagents for sequencing procedures is attributed to support the market growth and bolster the Nucleic Acid Sample Preparation market during the forecast period.
Key market players are introducing their new products and expanding their product portfolio. For instance, in February 2020, Miroculus Inc. introduced its Miro Canvas -a new system that can automate, simplify and miniaturize complex protocols like nest generation sequencing library preparation.
The Nucleic Acid Sample Preparation Market is segmented based on product, technology, therapeutic area, application, end users, and region. Based on product, the market is further segmented into consumables, systems, and accessories & components. Based on technology, the market is further segmented into spin-column-based technology, magnetic-bead-based technology, and others. Based on Therapeutic Area, the market is segmented into oncology, infectious disease, human genetics/population genetics, and others. Based on application, the market is further segmented into genomics, proteomics, and others. Based on end users, the market is further segmented into end users (academic and research institutions, pharmaceutical and biotechnology companies, clinical and diagnostic laboratories, and others. Based on the region, the market is further segmented into North America, Europe, Asia-Pacific, South America, and MEA.
BGI Group (MGI Tech Co., Ltd.), F. Hoffmann-La Roche Ltd, Danaher. (Beckman Coulter, Inc.), Eppendorf SE, Bioneer Corporation, Endress+Hauser Group Services AG (Analytik Jena GmbH), Merck KGaA, Norgen Biotek Corp, Aurora Biomed Inc., Agilent Technologies, Inc., are some of the major players operating in the global nucleic acid sample preparation Market.
In this report, Nucleic Acid Sample Preparation Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in Nucleic Acid Sample Preparation market.
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: